Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
The Bamboo Works

Hutchmed Roils Markets With Changing of Its Guard, U.S. Delisting Threat

Key Takeaways

  • U.S. securities regulator says Hutchmed is one of five Chinese companies in danger of delisting, a week after company announced the retirement of its longtime CEO
  • Company’s shares have tumbled more than 40% on the developments, even as it reported strong revenue gains for 2021 and nears its first approval to sell a drug in the U.S.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.